SalMar's Record Biology and Måsøval Deal: A Step Change in Scale and Efficiency

SalMar ASA (SALM.OL) reported Q2 2026 results that were defined by two headline events: a record biological performance and the acquisition of a 70% stake in Måsøval. The company raised its 2026 harvest volume guidance for Norway by 20,000 tons, bringing total guidance to 350,000 tons (up 16% year-over-year). CEO Frode Arntsen framed it simply: “Once again, SalMar delivers good biological and operational performance.” — Frode Arntsen, CEO · 2026-08-25 The numbers back that up: mortality 40% below the 10-year average, growth 33% above, and superior share 9pp higher. This isn't luck – it's the culmination of years of genetics, smolt quality, vaccines, and production strategy, all aligned on “salmon terms.”

Record Biology, Higher Guidance

The volume guidance increase is the most tangible expression of this biological strength. “We are increasing our volume guidance for Norway in 2026 by a further 20,000 tons.” — Frode Arntsen, CEO · 2026-08-25 This is the second upgrade this year; the company now expects 350,000 tons total, a 49,000-ton (16%) increase over 2025. Biological performance is the core driver – the company's standing biomass costs are down 38% year-to-date, and harvest volumes rose 30% in H1 vs. 5% for Norway overall. CFO Ulrik Steinvik noted that “SalMar is not simply participating in industry growth, SalMar is driving the industry growth.” — Ulrik Steinvik, CFO · 2026-08-25 The market is noticing: contract share for Q2 was 35%, and the company is already securing 2027 contracts, a sign of durable demand.

Cost Discipline and Structural Improvements

Beyond top-line volume, the cost trajectory is compelling. On-growth cost per kilo fell 12% year-over-year, with about one-third from feed and two-thirds from operational improvements. Cost per kilo improvements are embedded in standing biomass and will flow into earnings over coming quarters. “Improved fish quality, higher volumes, and lower costs are the key drivers behind the earnings improvement.” — Ulrik Steinvik, CFO · 2026-08-25 This is despite feed-price uncertainty; the company expects operational gains to offset most future feed inflation. The balance sheet strengthens too – net interest-bearing debt fell to 2.6x EBITDA, and available liquidity is NOK 14.4B, providing ample firepower for the Måsøval deal.

The Måsøval Acquisition – A Strategic Bet on Central Norway

The Måsøval acquisition is the company's largest inorganic move in years. Måsøval operates in production areas 5 and 6, where SalMar already has a strong footprint. The deal is expected to close in early 2027, pending approvals.

We believe this represents an exciting industrial opportunity that will further strengthen SalMar's position in central Norway.

Market Context and Demand

Global salmon supply growth is moderating, and demand remains resilient. Harvest volume is rising at SalMar while industry supply growth slows – a favorable position. The company's feed price commentary highlights a nuanced view: while feed costs are rising, the broader cost base is improving through technology and biology. “We expect ongoing operational improvements to largely compensate for those increases.” — Ulrik Steinvik, CFO · 2026-08-25 This confidence, backed by record biomics and a fortress balance sheet, makes SalMar one of the most compelling growth stories in Norwegian aquaculture.

In a macro environment dominated by tariff noise and geopolitical uncertainty, SalMar's story is refreshingly company-specific. The raised volume guidance and the Måsøval acquisition are evidence of a company that is not just riding a wave but actively creating its own. The market's reaction – positive volume growth and margin expansion – suggests investors are paying attention. The next catalyst is Q3, where the company expects further cost reductions and higher harvest volumes.